Sign Out
Pregnancy: Atorvastatin may cause fetal harm when administered to pregnant women. Atorvastatin is contraindicated in pregnant women. Atorvastatin should be administered to women of childbearing age only when such patients are highly unlikely to conceive and have been informed of the potential hazards. If the patient becomes pregnant while taking the drug, therapy should be discontinued and the patient apprised of the potential hazard to the fetus.
Lactation: It is not known whether atorvastatin is distributed into milk in humans. Because of the potential for serious adverse reactions from atorvastatin in nursing infants, the drug is contraindicated in nursing women.
